Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.114222.4.11.7239 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.114222.4.11.7239/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7239 |
Version | 20200807 |
Status | active |
Date | 2020-08-07T01:00:29-04:00 |
Name | NHSNContraindicationType |
Title | NHSNContraindicationType |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: NHSN surveillance reporting: Contraindication for using chlorhexidine gluconate (CHG) for Central Line Insertion Practices (CLIP) adherence monitoring),(Data Element Scope: A coded observation value representing the type of contraindication.),(Inclusion Criteria: ),(Exclusion Criteria: ) |
No resources found
CodeSystem | |
cdcnhsn.html | NHSN Surveillance System Codes |
No narrative content found in resource
{ "resourceType": "ValueSet", "id": "2.16.840.1.114222.4.11.7239", "meta": { "versionId": "5", "lastUpdated": "2023-12-21T17:43:03.000-05:00", "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ] }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/valueset-author", "valueContactDetail": { "name": "CDC NHSN Author" } }, { "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate", "valueDate": "2025-02-21" }, { "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate", "valueDate": "2020-08-07" } ], "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7239", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.114222.4.11.7239" } ], "version": "20200807", "name": "NHSNContraindicationType", "title": "NHSNContraindicationType", "status": "active", "experimental": false, "date": "2020-08-07T01:00:29-04:00", "publisher": "CDC NHSN", "jurisdiction": [ { "coding": [ { "system": "urn:iso:std:iso:3166", "code": "US" } ] } ], "purpose": "(Clinical Focus: NHSN surveillance reporting: Contraindication for using chlorhexidine gluconate (CHG) for Central Line Insertion Practices (CLIP) adherence monitoring),(Data Element Scope: A coded observation value representing the type of contraindication.),(Inclusion Criteria: ),(Exclusion Criteria: )", "compose": { "include": [ { "system": "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html", "concept": [ { "code": "6131-7", "display": "Patient is less than 2 months of age - chlorhexidine gluconate is to be used with caution in patients less than 2 months of age" }, { "code": "6132-5", "display": "Patient has a documented/known allergy/reaction to chlorhexidine gluconate-based products that would preclude its use" }, { "code": "6133-3", "display": "Facility restrictions or safety concerns for chlorhexidine gluconate use in premature infants precludes its use" } ] } ] }, "expansion": { "identifier": "urn:uuid:8a8e4548-9857-4e91-9e8f-152eea0f9f3c", "timestamp": "2025-05-23T23:55:55-04:00", "total": 3, "contains": [ { "system": "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html", "version": "2023-04", "code": "6131-7", "display": "Patient is less than 2 months of age - chlorhexidine gluconate is to be used with caution in patients less than 2 months of age" }, { "system": "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html", "version": "2023-04", "code": "6132-5", "display": "Patient has a documented/known allergy/reaction to chlorhexidine gluconate-based products that would preclude its use" }, { "system": "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html", "version": "2023-04", "code": "6133-3", "display": "Facility restrictions or safety concerns for chlorhexidine gluconate use in premature infants precludes its use" } ] } }